Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
Open Access
- 24 July 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs in R&D
- Vol. 17 (3), 329-339
- https://doi.org/10.1007/s40268-017-0197-5
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Pharmacokinetics, Drug Interactions and Exposure-Response Relationship of Eslicarbazepine Acetate in Adult Patients with Partial-Onset SeizuresCNS Drugs, 2012
- A Review of Eslicarbazepine Acetate for the Adjunctive Treatment of Partial-Onset EpilepsyJournal of Central Nervous System Disease, 2011
- Long‐term efficacy and safety of eslicarbazepine acetate: Results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsyEpilepsia, 2010
- Binding of licarbazepine enantiomers to mouse and human plasma proteinsBiopharmaceutics & Drug Disposition, 2010
- Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsyEpilepsy Research, 2010
- Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizuresActa Neurologica Scandinavica, 2009
- Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjectsFundamental & Clinical Pharmacology, 2009
- Eslicarbazepine Acetate: A Double‐blind, Add‐on, Placebo‐controlled Exploratory Trial in Adult Patients with Partial‐onset SeizuresEpilepsia, 2007
- The neurobiology of antiepileptic drugsNature Reviews Neuroscience, 2004
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresThe New England Journal of Medicine, 1985